Alveolar epithelial A2B adenosine receptors in pulmonary protection during acute lung injury

Journal of Immunology

Volumn 195, Issue 4, 2015, Pages 1815-1824

  Hoegl, Sandra ^a,b   Brodsky, Kelley S ^a   Blackburn, Michael R ^c   Karmouty Quintana, Harry ^c   Zwissler, Bernhard ^b   Eltzschig, Holger K ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A2B ADENOSINE RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; BAY 606583; UNCLASSIFIED DRUG; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS EPITHELIUM CELL; LUNG EDEMA; LUNG FLUID; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; ANTIBODY SPECIFICITY; DISEASE MODEL; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; METABOLISM; NEUTROPHIL; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ACUTE LUNG INJURY; ADENOSINE A2 RECEPTOR AGONISTS; ADMINISTRATION, INHALATION; ANIMALS; DISEASE MODELS, ANIMAL; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MACROPHAGES, ALVEOLAR; MICE; MICE, KNOCKOUT; NEUTROPHILS; ORGAN SPECIFICITY; PNEUMOCYTES; RECEPTOR, ADENOSINE A2B; SEVERITY OF ILLNESS INDEX;

EID: 84938944640     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401957     Document Type: Article

References (51)

1. Ware, L. B., and M. A. Matthay. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342: 1334-1349.
2. Ranieri, V. M., G. D. Rubenfeld, B. T. Thompson, N. D. Ferguson, E. Caldwell, E. Fan, L. Camporota, and A. S. Slutsky, ARDS Definition Task Force. 2012. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307: 2526-2533.
3. Matute-Bello, G., G. Downey, B. B. Moore, S. D. Groshong, M. A. Matthay, A. S. Slutsky, and W. M. Kuebler, Acute Lung Injury in Animals Study Group. 2011. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol. 44: 725-738.
4. Hudson, L. D., J. A. Milberg, D. Anardi, and R. J. Maunder. 1995. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151: 293-301.
5. Rubenfeld, G. D., E. Caldwell, E. Peabody, J. Weaver, D. P. Martin, M. Neff, E. J. Stern, and L. D. Hudson. 2005. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353: 1685-1693.
6. Herridge, M. S., C. M. Tansey, A. Matté, G. Tomlinson, N. Diaz-Granados, A. Cooper, C. B. Guest, C. D. Mazer, S. Mehta, T. E. Stewart, et al; Canadian Critical Care Trials Group. 2011. Functional disability 5 years after acute respiratory distress syndrome. N. Engl. J. Med. 364: 1293-1304.
7. Schelling, G., C. Stoll, C. Vogelmeier, T. Hummel, J. Behr, H. P. Kapfhammer, H. B. Rothenhäusler, M. Haller, K. Durst, T. Krauseneck, and J. Briegel. 2000. Pulmonary function and health-related quality of life in a sample of long-term survivors of the acute respiratory distress syndrome. Intensive Care Med. 26: 1304-1311.
8. Hoegl, S., M. Bachmann, P. Scheiermann, I. Goren, C. Hofstetter, J. Pfeilschifter, B. Zwissler, and H. Muhl. 2011. Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury. Am. J. Respir. Cell Mol. Biol. 44: 369-376.
9. Hoegl, S., K. A. Boost, H. Czerwonka, A. Dolfen, P. Scheiermann, H. Muhl, B. Zwissler, and C. Hofstetter. 2009. Inhaled IL-10 reduces biotrauma and mortality in a model of ventilator-induced lung injury. Respir. Med. 103: 463-470.
10. Eckle, T., M. Koeppen, and H. K. Eltzschig. 2009. Role of extracellular adenosine in acute lung injury. Physiology (Bethesda) 24: 298-306.
11. Idzko, M., D. Ferrari, and H. K. Eltzschig. 2014. Nucleotide signalling during inflammation. Nature 509: 310-317.
12. Jackson, E. K., J. Ren, and Z. Mi. 2009. Extracellular 29,39-cAMP is a source of adenosine. J. Biol. Chem. 284: 33097-33106.
13. Eckle, T., L. Füllbier, M. Wehrmann, J. Khoury, M. Mittelbronn, J. Ibla, P. Rosenberger, and H. K. Eltzschig. 2007. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J. Immunol. 178: 8127-8137.
14. Reutershan, J., I. Vollmer, S. Stark, R.Wagner, K. C. Ngamsri, and H. K. Eltzschig. 2009. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPSinduced PMN trafficking into the lungs. FASEB J. 23: 473-482.
15. Eltzschig, H. K., M. V. Sitkovsky, and S. C. Robson. 2012. Purinergic signaling during inflammation. N. Engl. J. Med. 367: 2322-2333.
16. Schingnitz, U., K. Hartmann, C. F. Macmanus, T. Eckle, S. Zug, S. P. Colgan, and H. K. Eltzschig. 2010. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J. Immunol. 184: 5271-5279.
17. Eckle, T., A. Grenz, S. Laucher, and H. K. Eltzschig. 2008. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J. Clin. Invest. 118: 3301-3315.
18. Thiel, M., A. Chouker, A. Ohta, E. Jackson, C. Caldwell, P. Smith, D. Lukashev, I. Bittmann, and M. V. Sitkovsky. 2005. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 3: e174.
19. Ohta, A., and M. Sitkovsky. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920.
20. Linden, J., and C. Cekic. 2012. Regulation of lymphocyte function by adenosine. Arterioscler. Thromb. Vasc. Biol. 32: 2097-2103.
21. Alva, J. A., A. C. Zovein, A. Monvoisin, T. Murphy, A. Salazar, N. L. Harvey, P. Carmeliet, and M. L. Iruela-Arispe. 2006. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev. Dyn. 235: 759-767.
22. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Förster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277.
23. Okubo, T., and B. L. Hogan. 2004. Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm. J. Biol. 3: 11.
24. Eckle, T., K. Hughes, H. Ehrentraut, K. S. Brodsky, P. Rosenberger, D. S. Choi, K. Ravid, T. Weng, Y. Xia, M. R. Blackburn, and H. K. Eltzschig. 2013. Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury. FASEB J. 27: 3078-3089.
25. Krombach, F., J. T. Gerlach, C. Padovan, A. Burges, J. Behr, T. Beinert, and C. Vogelmeier. 1996. Characterization and quantification of alveolar monocyte-like cells in human chronic inflammatory lung disease. Eur. Respir. J. 9: 984-991.
26. Singer, K., M. Frankenberger, J. Callegari, M. Königshoff, O. Eickelberg, and S. Krauss-Etschmann. 2011. Isolation of different pulmonary cell types from the mouse lung. Am. J. Respir. Crit. Care Med. 183: A5105.
27. Grenz, A., J. H. Kim, J. D. Bauerle, E. Tak, H. K. Eltzschig, and E. T. Clambey. 2012. Adora2b adenosine receptor signaling protects during acute kidney injury via inhibition of neutrophil-dependent TNF-A release. J. Immunol. 189: 4566-4573.
28. Reutershan, J., M. A. Morris, T. L. Burcin, D. F. Smith, D. Chang, M. S. Saprito, and K. Ley. 2006. Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J. Clin. Invest. 116: 695-702.
29. Messier, E. M., R. J. Mason, and B. Kosmider. 2012. Efficient and rapid isolation and purification of mouse alveolar type II epithelial cells. Exp. Lung Res. 38: 363-373.
30. Schneider, T., and A. C. Issekutz. 1996. Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase. Application in a Brown Norway rat model of allergic pulmonary inflammation. J. Immunol. Methods 198: 1-14.
31. Ehrentraut, H., E. T. Clambey, E. N. McNamee, K. S. Brodsky, S. F. Ehrentraut, J. M. Poth, A. K. Riegel, J. A. Westrich, S. P. Colgan, and H. K. Eltzschig. 2013. CD73+ regulatory T cells contribute to adenosine-mediated resolution of acute lung injury. FASEB J. 27: 2207-2219.
32. Hardiman, K. M., J. R. Lindsey, and S. Matalon. 2001. Lack of amiloridesensitive transport across alveolar and respiratory epithelium of iNOS2/2 mice in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L722-L731.
33. Smedira, N., L. Gates, R. Hastings, C. Jayr, T. Sakuma, J. F. Pittet, and M. A. Matthay. 1991. Alveolar and lung liquid clearance in anesthetized rabbits. J. Appl. Physiol. 70: 1827-1835.
34. Mikkelsen, M. E., C. V. Shah, N. J. Meyer, D. F. Gaieski, S. Lyon, A. N. Miltiades, M. Goyal, B. D. Fuchs, S. L. Bellamy, and J. D. Christie. 2013. The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis. Shock 40: 375-381.
35. Belikoff, B. G., S. Hatfield, P. Georgiev, A. Ohta, D. Lukashev, J. A. Buras, D. G. Remick, and M. Sitkovsky. 2011. A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice. J. Immunol. 186: 2444-2453.
36. Csóka, B., Z. H. Németh, P. Rosenberger, H. K. Eltzschig, Z. Spolarics, P. Pacher, Z. Selmeczy, B. Koscsó, L. Himer, E. S. Vizi, et al. 2010. A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation. J. Immunol. 185: 542-550.
37. Cramer, T., Y. Yamanishi, B. E. Clausen, I. Förster, R. Pawlinski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, et al. 2003. HIF-1a is essential for myeloid cell-mediated inflammation. Cell 112: 645-657.
38. Yang, D., M. Koupenova, D. J. McCrann, K. J. Kopeikina, H. M. Kagan, B. M. Schreiber, and K. Ravid. 2008. The A2b adenosine receptor protects against vascular injury. Proc. Natl. Acad. Sci. USA 105: 792-796.
39. Yang, D., Y. Zhang, H. G. Nguyen, M. Koupenova, A. K. Chauhan, M. Makitalo, M. R. Jones, C. St Hilaire, D. C. Seldin, P. Toselli, et al. 2006. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J. Clin. Invest. 116: 1913-1923.
40. Skuli, N., L. Liu, A. Runge, T. Wang, L. Yuan, S. Patel, L. Iruela-Arispe, M. C. Simon, and B. Keith. 2009. Endothelial deletion of hypoxia-inducible factor-2a (HIF-2a) alters vascular function and tumor angiogenesis. Blood 114: 469-477.
41. Cagnina, R. E., S. I. Ramos, M. A.Marshall, G.Wang, C. R. Frazier, and J. Linden. 2009. Adenosine A2B receptors are highly expressed on murine type II alveolar epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L467-L474.
42. Manzo, N. D., W. M. Foster, and B. R. Stripp. 2012. Amphiregulin-dependent mucous cell metaplasia in a model of nonallergic lung injury. Am. J. Respir. Cell Mol. Biol. 47: 349-357.
43. Eckle, T., E.M. Kewley, K. S. Brodsky, E. Tak, S. Bonney, M. Gobel, D. Anderson, L. E. Glover, A. K. Riegel, S. P. Colgan, and H. K. Eltzschig. 2014. Identification of hypoxia-inducible factor HIF-1A as transcriptional regulator of the A2B adenosine receptor during acute lung injury. J. Immunol. 192: 1249-1256.
44. Taylor, C. T., and J. C. McElwain. 2010. Ancient atmospheres and the evolution of oxygen sensing via the hypoxia-inducible factor in metazoans. Physiology (Bethesda) 25: 272-279.
45. Eltzschig, H. K., and P. Carmeliet. 2011. Hypoxia and inflammation. N. Engl. J. Med. 364: 656-665.
46. Taylor, C. T. 2008. Interdependent roles for hypoxia inducible factor and nuclear factor-kB in hypoxic inflammation. J. Physiol. 586: 4055-4059.
47. Eckle, T., K. Brodsky, M. Bonney, T. Packard, J. Han, C. H. Borchers, T. J. Mariani, D. J. Kominsky, M. Mittelbronn, and H. K. Eltzschig. 2013. HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium. PLoS Biol. 11: e1001665.
48. Karmouty-Quintana, H., H. Zhong, L. Acero, T. Weng, E. Melicoff, J. D. West, A. Hemnes, A. Grenz, H. K. Eltzschig, T. S. Blackwell, et al. 2012. The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease. FASEB J. 26: 2546-2557.
49. Blackburn, M. R., J. B. Volmer, J. L. Thrasher, H. Zhong, J. R. Crosby, J. J. Lee, and R. E. Kellems. 2000. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J. Exp. Med. 192: 159-170.
50. Sun, C. X., H. Zhong, A. Mohsenin, E. Morschl, J. L. Chunn, J. G. Molina, L. Belardinelli, D. Zeng, and M. R. Blackburn. 2006. Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J. Clin. Invest. 116: 2173-2182.
51. Zhou, Y., D. J. Schneider, E. Morschl, L. Song, M. Pedroza, H. Karmouty-Quintana, T. Le, C. X. Sun, and M. R. Blackburn. 2011. Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury. J. Immunol. 186: 1097-1106.